HALOZYME THERAPEUTICS INC - NOTE 0.250% 3/0

Historical Portfolio Holders from Q1 2022 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Debt / NOTE 0.250% 3/0
Principal, excl. options Q1 2024
625 M
Holdings value Q1 2024
$555 M
Value change Q1 2024
-$743 K
Grand Portfolio weight change Q1 2024
0%
Number of holders
57
Number of buys Q1 2024
20
Number of sells Q1 2024
-24
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
40637HAD1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q1 $625 M $555 M -$743 K $0.89 57
2023 Q4 $630 M $549 M +$12 M $0.86 61
2023 Q3 $615 M $523 M +$8.64 M $0.85 63
2023 Q2 $607 M $506 M +$19.2 M $0.83 64
2023 Q1 $649 M $551 M +$84.3 M $0.85 61
2022 Q4 $480 M $483 M +$18.5 M $0.97 53
2022 Q3 $474 M $386 M -$211 M $0.85 46
2022 Q2 $713 M $600 M +$140 M $0.88 49
2022 Q1 $543 M $460 M +$460 M $0.88 45